What is a stock summary page? Click here for an overview.
Business Description
CK Life Sciences International Holdings Inc
NAICS : 541711
ISIN : KYG2176J1058
Compare
Compare
Traded in other countries / regions
00775.Hong KongLSI.Germany Index Membership
Hong Kong Stock Connect IPO Date
2002-07-16Description
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The operating segments of the company are Agriculture-related and Health. The company derives maximum revenue from the health segment. The overall product portfolio of the company involves a presence that spans North America and the Asia Pacific.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.1 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 1.48 | |||||
| Debt-to-EBITDA | 12.9 | |||||
| Interest Coverage | 0.72 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.42 | |||||
| Beneish M-Score | -2.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.5 | |||||
| 3-Year EBITDA Growth Rate | 9.9 | |||||
| 3-Year FCF Growth Rate | 12.9 | |||||
| 3-Year Book Growth Rate | -3.9 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 83.32 | |||||
| 9-Day RSI | 72.05 | |||||
| 14-Day RSI | 66.85 | |||||
| 3-1 Month Momentum % | 23.81 | |||||
| 6-1 Month Momentum % | 50.72 | |||||
| 12-1 Month Momentum % | 23.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.97 | |||||
| Quick Ratio | 0.56 | |||||
| Cash Ratio | 0.2 | |||||
| Days Inventory | 119.74 | |||||
| Days Sales Outstanding | 66.77 | |||||
| Days Payable | 54.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | -7.2 | |||||
| Shareholder Yield % | 0.06 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.43 | |||||
| Operating Margin % | 4.69 | |||||
| Net Margin % | -0.35 | |||||
| FCF Margin % | 10.76 | |||||
| ROE % | -0.45 | |||||
| ROA % | -0.17 | |||||
| ROIC % | -2.75 | |||||
| 3-Year ROIIC % | 7.97 | |||||
| ROC (Joel Greenblatt) % | 8.74 | |||||
| ROCE % | 4.35 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 27.5 | |||||
| Price-to-Owner-Earnings | 78.57 | |||||
| PS Ratio | 0.98 | |||||
| PB Ratio | 1.31 | |||||
| Price-to-Tangible-Book | 11 | |||||
| Price-to-Free-Cash-Flow | 9.17 | |||||
| Price-to-Operating-Cash-Flow | 9.17 | |||||
| EV-to-EBIT | 29.34 | |||||
| EV-to-EBITDA | 23.35 | |||||
| EV-to-Revenue | 2 | |||||
| EV-to-FCF | 18.43 | |||||
| Price-to-GF-Value | 0.69 | |||||
| Price-to-Projected-FCF | 1.17 | |||||
| Price-to-Median-PS-Value | 0.71 | |||||
| Earnings Yield (Greenblatt) % | 3.41 | |||||
| FCF Yield % | 10.95 | |||||
| Forward Rate of Return (Yacktman) % | 2.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CK Life Sciences International Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 5,379.456 | ||
| EPS (TTM) (HK$) | -0.002 | ||
| Beta | 0.55 | ||
| 3-Year Sharpe Ratio | -0.18 | ||
| 3-Year Sortino Ratio | -0.27 | ||
| Volatility % | 50.82 | ||
| 14-Day RSI | 66.85 | ||
| 14-Day ATR (HK$) | 0.025285 | ||
| 20-Day SMA (HK$) | 0.51125 | ||
| 12-1 Month Momentum % | 23.81 | ||
| 52-Week Range (HK$) | 0.3 - 0.61 | ||
| Shares Outstanding (Mil) | 9,611.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CK Life Sciences International Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CK Life Sciences International Holdings Inc Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
CK Life Sciences International Holdings Inc Frequently Asked Questions
What is CK Life Sciences International Holdings Inc(HKSE:00775)'s stock price today?
The current price of HKSE:00775 is HK$0.55. The 52 week high of HKSE:00775 is HK$0.61 and 52 week low is HK$0.30.
When is next earnings date of CK Life Sciences International Holdings Inc(HKSE:00775)?
The next earnings date of CK Life Sciences International Holdings Inc(HKSE:00775) is .
Does CK Life Sciences International Holdings Inc(HKSE:00775) pay dividends? If so, how much?
CK Life Sciences International Holdings Inc(HKSE:00775) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers